Ads
    Related paper
  1. Management of Rheumatoid Arthritis and Effectiveness of Disease Modifying Anti-Rheumatic Drug Therapy
  2. COMPARISON OF CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS WITH AND WITHOUT INTRA-ARTICULAR PLATELET RICH PLASMA INJECTION IN THE ALTERATION OF DISEASE PROGRESSION OF EARLY RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL
  3. Serum anti-cyclic citrullinated peptide antibodies before and after treatment by disease-modifying anti-rheumatic drugs
  4. Disease severity and time to diagnosis in 100 patients with newly diagnosed disease modifying antirheumatic drugs treatment-naïve rheumatoid arthritis
  5. Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis
  6. Effects of silymarin as adjuvant drug on serum levels of CTRP3, anti-cyclic citrullinated peptide (CCP), and high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis patients
  7. Comparison of comorbidities between rheumatoid and psoriatic arthritis in a tertiary care rheumatic center
  8. Study of Prognostic Value of Rheumatoid Factor and Anti Cyclic Citrullinated Peptide Antibodies in Patients with Rheumatoid Arthritis
  9. The Relationship of Rheumatoid Factor with Disease Activity in Patients with Rheumatoid Arthritis
  10. Serological and Genetic Evidence of Celiac Disease in Juvenile Arthritis and Rheumatoid Arthritis